Powered by ZigaForm version
(Last Updated On: January 27, 2022)

Public Alert No: 001/2022 – Efficient Laboratories, Inc. Expands Voluntary Nationwide Recall to Consumers to Include Twelve Additional Lots of Rompe Pecho CF, Rompe Pecho EX, Rompe Pecho MAX, and Rompe Pecho DM Sold in 2019 Due to Microbial Contamination Concerns

January 26, 2022,

The National Agency for Food and Drug Administration and Control (NAFDAC) has been informed by U.S Food and drug Administration (FDA) that Efficient Laboratories Miami, Florida. is expanding its voluntary recall to consumers to include twelve lots of Rompe Pecho CF, Rompe Pecho EX, Rompe Pecho MAX, and Rompe Pecho DM due to microbial contamination concerns. These lots were distributed in 2019. To date, Efficient Laboratories has not received any reports of adverse events.

In rare circumstances, consumption of these specific lots could result in illness. These products are used to treat symptoms of the flu and the common cold, and each are packaged in a box containing a bottle of the liquid product.

The affected twelve lots of Rompe Pecho product are listed below:

Brand Name Lots Expiry Manufacturer
Rompe Pecho CF 19F88 Exp. Jun. 2022 Efficient Laboratories Miami, Florida.
19G164 Exp. Jul. 2022
Rompe Pecho DM 19F168 Exp. Jun. 2022
19G145 Exp. Jul. 2022
19G361 Exp. Jul. 2022
19G449 Exp. Jul. 2022
19G491 Exp. Jul. 2022
Rompe Pecho EX 19H20 Exp. Aug.2022
19J98 Exp. Sep. 2022
19A418 Exp. Jan. 2022
19E411 Exp. May 2022
Rompe Pecho MAX 19G219 Exp. Jul. 2022

The lot numbers and expiration dates can be found on the bottom of the cartons. These Rompe Pecho products were distributed nationwide to wholesalers and retailers.

Consumers that have Rompe Pecho EX, Rompe Pecho CF, Rompe Pecho DM, or Rompe Pecho MAX from these lots that are being recalled should stop using these products and submit them to the nearest NAFDAC office.

Consumers should contact their physician or healthcare providers if they have experience any problem that may be related to taking or using this medicinal product.

Healthcare professionals and Consumers are encouraged to report any problem related to the use of this product to the nearest NAFDAC office, NAFDAC PRASCOR (20543 TOLL FREE from all networks) or via pharmacovigilance@nafdac.gov.ng or via e reporting platform available on NAFDAC websites www.nafdac.gov.ng or via Med Safety application available for download on Android and IOS.

NAFDAC……..Customer-focused, Agency-minded!!!

Signed Management

Was this post helpful?